Foto del docente

Nicoletta Testoni

Professoressa associata

Dipartimento di Scienze Mediche e Chirurgiche

Settore scientifico disciplinare: MED/15 MALATTIE DEL SANGUE

Pubblicazioni

Rosti G; Iacobucci I; Bassi S; Castagnetti F; Amabile M; Cilloni D; Poerio A; Soverini S; Palandri F; Rege Cambrin G; Iuliano F; Alimena G; Latagliata R; Testoni N; Pane F; Saglio G; Baccarani M; Martinelli G., Impact of age on the outcome of patients with chronic myeloid leukemia in late chronic phase: results of a phase II study of the GIMEMA CML Working Party., «HAEMATOLOGICA», 2007, 92, pp. 101 - 105 [articolo]

Palmisano M; Grafone T; Ottaviani E; Testoni N; Baccarani M; Martinelli G., NPM1 mutations are more stable than FLT3 mutations during the course of disease in patients with acute myeloid leukemia., «HAEMATOLOGICA», 2007, 92(9):, pp. 1268 - 1269 [articolo]

Soverini S; Colarossi S; Gnani A; Castagnetti F; Rosti G; Bosi C; Paolini S; Rondoni M; Piccaluga PP; Palandri F; Giannoulia P; Marzocchi G; Luatti S; Testoni N; Iacobucci I; Cilloni D; Saglio G; Baccarani M; Martinelli G., Resistance to dasatinib in Philadelphia-positive leukemia patients and the presence or the selection of mutations at residues 315 and 317 in the BCR-ABL kinase domain, «HAEMATOLOGICA», 2007, 92, pp. 401 - 404 [articolo]

Baccarani M; Cilloni D; Rondoni M; Ottaviani E; Messa F; Merante S; Tiribelli M; Buccisano F; Testoni N; Gottardi E; de Vivo A; Giugliano E; Iacobucci I; Paolini S; Soverini S; Rosti G; Rancati F; Astolfi C; Pane F; Saglio G; Martinelli G., The efficacy of imatinib mesylate in patients with FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome. Results of a multicenter prospective study., «HAEMATOLOGICA», 2007, 92, pp. 1173 - 1179 [articolo]

Iacobucci I; Saglio G; Rosti G; Testoni N; Pane F; Amabile M; Poerio A; Soverini S; Bassi S; Cilloni D; Bassan R; Breccia M; Lauria F; Izzo B; Merante S; Frassoni F; Paolini S; Montefusco E; Baccarani M; Martinelli G, Achieving a major molecular response at the time of a complete cytogenetic response (CCgR) predicts a better duration of CCgR in imatinib-treated chronic myeloid leukemia patients., «CLINICAL CANCER RESEARCH», 2006, 12, pp. 3037 - 3042 [articolo]

IACOBUCCI I; ROSTI G; AMABILE M; POERIO A; SOVERINI S; CILLONI D; TESTONI N; ABRUZZESE E; MONTEFUSCO E; OTTAVIANI E; IULIANO F; RUSSO D; GOBBI M; ALIMENA G; MARTINO B; TERRAGNA C; PANE F; SAGLIO G; BACCARANI M; MARTINELLI G, Comparison between patients with Philadelphia-positive chronic phase chronic myeloid leukemia who obtained a complete cytogenetic response within 1 year of imatinib therapy and those who achieved such a response after 12 months of treatment., «JOURNAL OF CLINICAL ONCOLOGY», 2006, 24, pp. 454 - 459 [articolo]

La Starza R; Aventin A; Matteucci C; Crescenzi B; Romoli S; Testoni N; Pierini V; Ciolli S; Sambani C; Locasciulli A; Di Bona E; Lafage-Pochitaloff M; Martelli MF; Marynen P; Mecucci C., Genomic gain at 6p21: a new cryptic molecular rearrangement in secondary myelodysplastic syndrome and acute myeloid leukemia., «LEUKEMIA», 2006, 20, pp. 958 - 964 [articolo]

Piccaluga PP; Malagola M; Rondoni M; Ottaviani E; Testoni N; Laterza C; Visani G; Pileri SA; Martinelli G; Baccarani M., Poor outcome of adult acute lymphoblastic leukemia patients carrying the (1;19)(q23;p13) translocation., «LEUKEMIA & LYMPHOMA», 2006, 47, pp. 469 - 472 [articolo]

Cavo M; Terragna C; Renzulli M; Zamagni E; Tosi P; Testoni N; Nicci C; Cangini D; Tacchetti P; Grafone T; Cellini C; Ceccolini M; Perrone G; Martinelli G; Baccarani M; Guardigni L., Poor outcome with front-line autologous transplantation in t(4;14) multiple myeloma: low complete remission rate and short duration of remission., «JOURNAL OF CLINICAL ONCOLOGY», 2006, 24, pp. e4 - e5 [articolo]

MARTINELLI G; IACOBUCCI I; ROSTI G; PANE F; AMABILE M; CASTAGNETTI F; CILLONI D; SOVERINI S; TESTONI N; SPECCHIA G; MERANTE S; ZACCARIA A; FRASSONI F; SAGLIO G; BACCARANI M., Prediction of response to imatinib by prospective quantitation of BCR-ABL transcript in late chronic phase chronic myeloid leukemia patients, «ANNALS OF ONCOLOGY», 2006, 17, pp. 495 - 502 [articolo]

S. Soverini;G. Martinelli;S. Colarossi;A. Gnani;F. Castagnetti;G. Rosti;C. Bosi;S. Paolini;M. Rondoni;P. P. Piccaluga;F. Palandri;P. Giannoulia;G. Marzocchi;S. Luatti;N. Testoni;I. Iacobucci;D. Cilloni;G. Saglio;M. Baccarani, Presence or the Emergence of a F317L BCR-ABL Mutation May Be Associated With Resistance to Dasatinib in Philadelphia Chromosome Positive Leukemia, «JOURNAL OF CLINICAL ONCOLOGY», 2006, 24, pp. e51 - e52 [articolo]

Soverini S; Martinelli G; Rosti G; Bassi S; Amabile M; Poerio A; Giannini B; Trabacchi E; Castagnetti F; Testoni N; Luatti S; de Vivo A; Cilloni D; Izzo B; Fava M; Abruzzese E; Alberti D; Pane F; Saglio G; Baccarani M., ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party on Chronic Myeloid Leukemia, «JOURNAL OF CLINICAL ONCOLOGY», 2005, 23, pp. 4100 - 4109 [articolo]

Curti A.; Pandolfi S.; Aluigi M.; Isidori A.; Alessandrini I.; Chiodoni C.; Testoni N.; Colombo MP.; Baccarani M.; Lemoli RM., Interleukin-12 production by leukemia-derived dendritic cells counteracts the inhibitory effect of leukemic microenvironment on T cells., «EXPERIMENTAL HEMATOLOGY», 2005, 33, pp. 1521 - 1530 [articolo]

NICCI C; OTTAVIANI E; LUATTI S; GRAFONE T; TONELLI M; MOTTA MR; MALAGOLA M; MARZOCCHI G; MARTINELLI G; BACCARANI M; TESTONI N., Molecular and cytogenetic characterization of a new case of t(5;17)(q35;q21) variant acute promyelocytic leukemia, «LEUKEMIA», 2005, 19, pp. 470 - 472 [articolo]

Russo D; Malagola M; Vivo A; Fiacchini M; Martinelli G; Piccaluga PP; Damiani D; Candoni A; Michielutti A; Castelli M; Testoni N; Ottaviani E; Rondoni M; Pricolo G; Mazza P; Zuffa E; Zaccaria A; Raspadori D; Bocchia M; Lauria F; Bonini A; Avanzini P; Gugliotta L; Visani G; Fanin R; Baccarani M, Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients, «BRITISH JOURNAL OF HAEMATOLOGY», 2005, 131(2), pp. 172 - 179 [articolo]

Ultimi avvisi

Al momento non sono presenti avvisi.